These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9721598)

  • 1. Receptor binding profile of Otilonium bromide.
    Evangelista S; Giachetti A; Chapelain B; Neliat G; Maggi CA
    Pharmacol Res; 1998 Aug; 38(2):111-7. PubMed ID: 9721598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon.
    Santicioli P; Zagorodnyuk V; Renzetti AR; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):420-7. PubMed ID: 10498293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.
    Lindqvist S; Hernon J; Sharp P; Johns N; Addison S; Watson M; Tighe R; Greer S; Mackay J; Rhodes M; Lewis M; Stebbings W; Speakman C; Evangelista S; Johnson I; Williams M
    Br J Pharmacol; 2002 Dec; 137(7):1134-42. PubMed ID: 12429587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.
    Traini C; Evangelista S; Girod V; Faussone-Pellegrini MS; Vannucchi MG
    J Cell Mol Med; 2017 Apr; 21(4):735-745. PubMed ID: 27866394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of otilonium bromide (OB) in human cultured smooth muscle cells and rat colonic strips.
    Martínez-Cutillas M; Gil V; Gallego D; Mañé N; Martín MT; Jiménez M
    Neurogastroenterol Motil; 2013 Dec; 25(12):e803-12. PubMed ID: 23941257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of otilonium bromide on contractile patterns in the human sigmoid colon.
    Gallego D; Aulí M; Aleu J; Martínez E; Rofes L; Martí-Ragué J; Jiménez M; Clavé P
    Neurogastroenterol Motil; 2010 Jun; 22(6):e180-91. PubMed ID: 20367799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon.
    Martin MT; Hove-Madsen L; Jimenez M
    Neurogastroenterol Motil; 2004 Apr; 16(2):175-83. PubMed ID: 15086871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment with otilonium bromide induces changes in L-type Ca²⁺ channel, tachykinins, and nitric oxide synthase expression in rat colon muscle coat.
    Traini C; Cipriani G; Evangelista S; Santicioli P; Faussone-Pellegrini MS; Vannucchi MG
    Neurogastroenterol Motil; 2013 Nov; 25(11):e728-39. PubMed ID: 23901937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner and outer portions of colonic circular muscle: ultrastructural and immunohistochemical changes in rat chronically treated with otilonium bromide.
    Traini C; Faussone-Pellegrini MS; Evangelista S; Mazzaferro K; Cipriani G; Santicioli P; Vannucchi MG
    PLoS One; 2014; 9(8):e103237. PubMed ID: 25122192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies on otilonium bromide.
    Giachetti A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):56-9. PubMed ID: 1661629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otilonium: a potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells.
    Gandía L; Villarroya M; Lara B; Olmos V; Gilabert JA; López MG; Martínez-Sierra R; Borges R; García AG
    Br J Pharmacol; 1996 Feb; 117(3):463-470. PubMed ID: 8821535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ; Bonner TI; Buckley CM; Brann MR
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of selective muscarinic receptor antagonists on guinea-pig ileal smooth muscle.
    Doods HN; Entzeroth M; Ziegler H; Mayer N; Holzer P
    Eur J Pharmacol; 1994 Mar; 253(3):275-81. PubMed ID: 8200421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy.
    Mazzone SB; Mori N; Burman M; Palovich M; Belmonte KE; Canning BJ
    J Physiol; 2006 Aug; 575(Pt 1):23-35. PubMed ID: 16728454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
    Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.
    Giraldo E; Viganò MA; Hammer R; Ladinsky H
    Mol Pharmacol; 1988 Jun; 33(6):617-25. PubMed ID: 3380078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G
    Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.